Elagolix in the treatment of menstrual bleeding with Uterine Fibriods

• Research type

  Research Study

• Full title

  A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

• IRAS ID

  134592

• Contact name

  Edward Patrick Morris

• Contact email

  edward.morris@nnuh.nhs.uk

• Sponsor organisation

  AbbVie Deutschland GmbH & Co. KG

• Eudract number

  2013-000082-37

• Clinicaltrials.gov Identifier

  NCT01817530

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0377

• Date of REC Opinion

  23 Dec 2013

• REC opinion

  Further Information Favourable Opinion